@inproceedings{aiello_cost-effectiveness_2007,
	address = {Arlington, VA, USA},
	title = {Cost-effectiveness of new targeted therapy sunitinib malate as second line treatment in metastatic renal cell carcinoma in {Argentina}.},
	author = {Aiello, E. C. and Muszbek, N. and Richardet, E. and Lingua, A. and Charbonneau, C. and Remák, E.},
	year = {2007},
	keywords = {oncology},
}

{"_id":"E4Z7SgL6QGwRiPmuH","bibbaseid":"aiello-muszbek-richardet-lingua-charbonneau-remk-costeffectivenessofnewtargetedtherapysunitinibmalateassecondlinetreatmentinmetastaticrenalcellcarcinomainargentina-2007","authorIDs":[],"author_short":["Aiello, E. C.","Muszbek, N.","Richardet, E.","Lingua, A.","Charbonneau, C.","Remák, E."],"bibdata":{"bibtype":"inproceedings","type":"inproceedings","address":"Arlington, VA, USA","title":"Cost-effectiveness of new targeted therapy sunitinib malate as second line treatment in metastatic renal cell carcinoma in Argentina.","author":[{"propositions":[],"lastnames":["Aiello"],"firstnames":["E.","C."],"suffixes":[]},{"propositions":[],"lastnames":["Muszbek"],"firstnames":["N."],"suffixes":[]},{"propositions":[],"lastnames":["Richardet"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Lingua"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Charbonneau"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Remák"],"firstnames":["E."],"suffixes":[]}],"year":"2007","keywords":"oncology","bibtex":"@inproceedings{aiello_cost-effectiveness_2007,\n\taddress = {Arlington, VA, USA},\n\ttitle = {Cost-effectiveness of new targeted therapy sunitinib malate as second line treatment in metastatic renal cell carcinoma in {Argentina}.},\n\tauthor = {Aiello, E. C. and Muszbek, N. and Richardet, E. and Lingua, A. and Charbonneau, C. and Remák, E.},\n\tyear = {2007},\n\tkeywords = {oncology},\n}\n\n","author_short":["Aiello, E. C.","Muszbek, N.","Richardet, E.","Lingua, A.","Charbonneau, C.","Remák, E."],"key":"aiello_cost-effectiveness_2007","id":"aiello_cost-effectiveness_2007","bibbaseid":"aiello-muszbek-richardet-lingua-charbonneau-remk-costeffectivenessofnewtargetedtherapysunitinibmalateassecondlinetreatmentinmetastaticrenalcellcarcinomainargentina-2007","role":"author","urls":{},"keyword":["oncology"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"inproceedings","biburl":"https://bibbase.org/zotero/visiblePublications","creationDate":"2019-10-29T15:48:35.514Z","downloads":0,"keywords":["oncology"],"search_terms":["cost","effectiveness","new","targeted","therapy","sunitinib","malate","second","line","treatment","metastatic","renal","cell","carcinoma","argentina","aiello","muszbek","richardet","lingua","charbonneau","remák"],"title":"Cost-effectiveness of new targeted therapy sunitinib malate as second line treatment in metastatic renal cell carcinoma in Argentina.","year":2007,"dataSources":["sMi9tjFo5gDXmBZje","zeMwFvgpdRkYAkfoD"]}